MedPath
NMPA Approval

Isepamicin Sulfate Injection

国药准字HJ20171234

August 31, 2022

H20171234

Drug Information

硫酸异帕米星注射液

依克沙

注射剂

2ml:0.2g(按C₂₂H₄₃N₅O₁₂计)

化学药品

August 31, 2022

August 30, 2027

Company Information

Applicant Company

1-1-2 Yurakucho, Chiyoda-ku, Tokyo, Japan

Manufacturing Company

asahi kasei pharma corporation,nagoya pharmaceuticals plant

61 Ikeda Fukuta-cho,Miyoshi-shi,Aichi,Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硫酸异帕米星注射液 - NMPA 批准文号 | MedPath